Examining the Experiences of Children With Blood Disorders

Status Recruiting

Clinical Trial Summary

This is a 3-phase mixed methods study design. A literature review (Phase 1) has been completed to determine the areas of exploration and to identify challenges faced and the impact of the blood disorder on pediatric patients. Based on Phase 1, Phases 2 and 3, as proposed in this study, will be completed and will include interviews of patients diagnosed with bleeding and thrombotic disorders (phase 2). The interviews will be individual, semi-structured, and consist of open-ended questions to elicit unbiased and in-depth responses to gain an understanding of participant's perspectives on themes predetermined in the study design phase.

Clinical Trial Description

The purpose of this study is to explore the experiences of pediatric patients with blood disorders, specifically thrombotic, including venous thromboembolism (VTE), and hemostatic or bleeding disorders. The information gleaned from this study will help identify specific challenges faced by patients with hemostatic and thrombotic disorders - information that is necessary to develop impactful, evidence-based solutions to support patients with hemostatic and thrombotic disorders cope with the physical, emotional, and psychological impact of blood disorders. Participants with blood disorders in this study will participate in open-ended, semi-structured interviews with a study investigator focusing on the psychosocial experiences of patients with diagnosis and treatment of their underlying disorder and the understanding of their diagnosis. Female participants additionally will be asked questions about the unique effects of heavy menstrual bleeding, either from their underlying blood disorder or secondary to anticoagulation, on similar aspects of the impact of having a blood disorder. Validated questionnaires will be completed to obtain concurrent quantitative data. The interviews will be recorded and transcribed. Participation is complete after the interview has finished; participants will continue to receive standard of care treatment during and beyond the study period. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04600609
Study type	Observational
Source	University of Texas Southwestern Medical Center
Contact	Ayesha Zia, MD
Phone	214-456-7000
Email	Ayesha.Zia@utsouthwestern.edu
Status	Recruiting
Phase
Start date	November 9, 2020
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05347550` - Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-risk Surgical Patients	N/A
Enrolling by invitation	`NCT05794165` - Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism	Phase 2
Completed	`NCT02379806` - The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study	Phase 3
Recruiting	`NCT03691753` - Safety and Efficacy Study of Fitaya Vena Cava Filter	N/A
Completed	`NCT02197416` - Safety of Dabigatran Etexilate in Blood Clot Prevention in Children	Phase 3
Recruiting	`NCT05378035` - DOAC in Chinese Patients With Atrial Fibrillation
Recruiting	`NCT05171075` - A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE	Phase 3
Completed	`NCT01895777` - Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)	Phase 3
Completed	`NCT05897697` - Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
Completed	`NCT04736719` - Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims Data
Completed	`NCT04735523` - Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims Data
Completed	`NCT04736420` - Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data
Completed	`NCT02829957` - RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding	Phase 2/Phase 3
Completed	`NCT02746185` - Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban	Phase 3
Completed	`NCT02912234` - Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants	Phase 1
Completed	`NCT02334007` - Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery	Phase 1/Phase 2
Completed	`NCT02223260` - Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age	Phase 2
Completed	`NCT02661568` - Description of Patients With Acute Venous Thromboembolism in the UK's Clinical Practice Research Datalink Linked With Hospital Episode Statistics Dataset (CPRD-HES)	N/A
Completed	`NCT01972243` - Risk of Recurrent Venous Thrombosis: A Validation Study of the Vienna Prediction Model
Completed	`NCT01431456` - Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery	Phase 3